Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study

Although risperidone is increasingly used for behavioral indications in children, the associated adverse events (AEs) are not well defined in this population. We determined the incidence of and risk factors for AEs among children treated with risperidone at our institution, an academic medical center with inpatient, outpatient, generalist, and specialist pediatric care. The study included children aged ≤ 18 years with ≥ 4 weeks of risperidone...